TheProfitWatch

COEP - Coeptis Therapeutics Holdings Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
15.84 -0.54 (-3.41%) --- --- --- 0.0 (0.0%) -0.53 (-3.35%) --- 0.0 (0.0%)

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

Category: FINANCE SERVICES
Market Period: Market

Earnings & Ratios

Basic EPS:
-1.17
Diluted EPS:
-1.17
Basic P/E:
-13.0769
Diluted P/E:
-13.0769
RSI(14) 1m:
100.0
VWAP:
15.31
RVol:
0.2418

Events

Period Kind Movement Occurred At
1m Price decrease 1m 15.05 -0.44 (-2.84%) Oct 15 09:51

Related News